Neuropsychopharmacology
- Knockdown of USP22 alleviates LPS-induced microglial inflammation and mouse depressive-like behaviors via KAT2A4 months ago
- Social environment as a determinant of mismatch negativity in early psychosis4 months ago
- Prefrontal contribution to passive coping behaviour in chronic stress and treatment by fast-acting antidepressant4 months ago
- Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder4 months ago
- The generative AI blueprint: modeling brain and behavior in concert4 months ago
- Ro 64-6198, a selective NOP receptor agonist attenuates social impairments associated with NTG-induced migraine pain4 months ago
- Epigenetic regulation of brain development, plasticity, and response to early-life stress4 months ago
Journal of Psychopharmacology
- Naturalistic use of psychedelics is associated with longitudinal improvements in anxiety and depression during global crisis times6 months ago
- Uncertainty about lithium and suicide: A response to Nassir Ghaemi6 months ago
- Dissecting the pro-neurogenic effects of monoaminergic medications used to treat depression: a systematic review and meta-analysis6 months ago
- A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy6 months ago
- Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder6 months ago
- Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression – comparison with ketamine, fluoxetine and lithium6 months ago
- What are set and setting: Reducing vagueness to improve research and clinical practice6 months ago
European Neuropsychopharmacology
- Predicting 10-year risk of chronic kidney disease in lithium-treated patients with bipolar disorder: A risk model development and internal cross-validation study8 months ago
- Negative Symptoms in Schizophrenia: The Placebo Effect as a Barrier to Drug Development?8 months ago
- Racial and ethnic diversity in zuranolone and brexanolone clinical trials for postpartum depression: A cross-sectional analysis of ClinicalTrials.gov8 months ago
- Creatine as a treatment for depression: A brain bioenergetics perspective8 months ago
- Rethinking suicide prediction: From static risk factors to dynamic models8 months ago
- Frequency, correlates and outcomes of Benzodiazepine use during Cariprazine treatment: A pooled post-hoc analysis from four 6-week, placebo-controlled trials in patients with an acute exacerbation of schizophrenia9 months ago
- Letter to the editor: Premature conclusions on antipsychotic continuation in environmentally conscious psychopharmacotherapy9 months ago